ConductScience.org, home

Paper21068

Alclofenac: a review of its pharmacological properties and therapeutic efficacy in rheumatoid arthritis and allied rheumatic disorders.

Brogden RN and 3 others. Drugs, 1977. Cited by 20 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Alclofenac: a review of its pharmacological properties and therapeutic efficacy in rheumatoid arthritis and allied rheumatic disorders. Papers, record 21068. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/21068

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Alclofenac: a review of its pharmacological properties and therapeutic efficacy in rheumatoid arthritis and allied rheumatic disorders.
PubMed
Journal
Drugs
PubMed
Year
1977
PubMed
Publication types
Clinical Trial, Comparative Study, Journal Article
PubMed
Citations, by iCite
20
iCite
Relative citation ratio, by iCite
1.17
iCite
Revised in PubMed
2026-10-11
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Brogden RNR N
2Heel RCR C
3Speight TMT M
4Avery GSG S

Source PubMed

Topics19

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Arthritis, RheumatoidMajor topic
PhenylacetatesMajor topic
Animals
Back Pain
Clinical Trials as Topic
Dose-Response Relationship, Drug
Double-Blind Method
Female
Gastrointestinal Hemorrhage
Humans
Intestinal Absorption
Metabolic Clearance Rate
Osteoarthritis
Platelet Aggregation
Pregnancy
Prostaglandins
Protein Binding
Sciatica
Spondylitis, Ankylosing

Source PubMed

References53

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
14,397,204Sulfhydryl deficiency in connective tissue disorders: correlation with disease activity and protein alterations.Metabolism1971https://conductscience.org/library/papers/4397204PubMed
24,618,390[Comparison of the activity of alclofenac and of acetylsalicylic acid in rheumatoid arthritis; a double blind study and cross permutation].Therapie1974https://conductscience.org/library/papers/4618390PubMed
3241,596Serum sulphydryl levels in rheumatoid patients treated with alclofenac.Curr Med Res Opin1975https://conductscience.org/library/papers/241596PubMed
44,192,958Factors influencing platelet function: adhesion, release, and aggregation.Pharmacol Rev1970https://conductscience.org/library/papers/4192958PubMed
5241,598The influence of alclofenac treatment on acute-phase proteins, plasma tryptophan, and erythrocyte sedimentation rate in patients with rheumatoid arthritis.Curr Med Res Opin1975https://conductscience.org/library/papers/241598PubMed
64,587,549Effects of recently developed antiphlogistic drugs on viability, reduplication, mean volume and volume distribution of mammalian cells cultured in vitro.Pharmacology1973https://conductscience.org/library/papers/4587549PubMed
7240,140[4-allyloxy-3-chlorophenyl-acetic acid (alclofenac) in the treatment of painful arthroses in the aged. Double-blind controlled clinical trial].Minerva Med1975https://conductscience.org/library/papers/240140PubMed
8238,274A study of the influence of various antirheumatic drug regimens on serum acute-phase proteins, plasma tryptophan, and erythrocyte sedimentation rate in rheumatoid arthritis.Rheumatol Rehabil1975https://conductscience.org/library/papers/238274PubMed
94,989,683Double-blind comparison between 4-allyloxy-3-chlorophenylacetic acid (alclofenac) and phenylbutazone in osteoarthritis.Curr Ther Res Clin Exp1970https://conductscience.org/library/papers/4989683PubMed
10241,593The chemical and biological background to alclofenac.Curr Med Res Opin1975https://conductscience.org/library/papers/241593PubMed
114,911,592Therapeutic activity of 4-allyloxy-3-chlorophenylacetic acid.Arzneimittelforschung1970https://conductscience.org/library/papers/4911592PubMed
124,546,491Proceedings: Plasma L-tryptophan concentrations in chronic rheumatic diseases and the effects of some antirheumatic drugs on the binding of the amino-acid to plasma proteins in vivo and in vitro.Rheumatol Rehabil1974https://conductscience.org/library/papers/4546491PubMed
134,397,176The displacement of L-tryptophan and dipeptides from bovine albumin in vitro and from human plasma in vivo by antirheumatic drugs.J Pharm Pharmacol1971https://conductscience.org/library/papers/4397176PubMed
144,279,126Vasculitis with alclofenac therapy.Br Med J1974https://conductscience.org/library/papers/4279126PubMed
154,563,533A double-blind crossover trial comparing a new antirheumatic agent alclofenac with phenylbutazone in chronic rheumatic disorders.Br J Clin Pract1972https://conductscience.org/library/papers/4563533PubMed
161,079Angioneurotic oedema with alclofenac therapy.Br J Clin Pract1975https://conductscience.org/library/papers/1079PubMed
174,602,026
Studies on 4-allyloxy-3 chlorophenylacetic acid (Alcofenac). A double-blind comparison of Alcofenac and aspirin in rheumatoid arthritis, and effects of therapy on serum immunoglobulins and rheumatoid factor.
Ann Rheum Dis1974https://conductscience.org/library/papers/4602026PubMed
184,129,243Letter: Reactions to alclofenac.Lancet1974https://conductscience.org/library/papers/4129243PubMed
194,561,431The assessment of rheumatoid arthritis. A study based on measurements of the serum acute-phase reactants.Q J Med1972https://conductscience.org/library/papers/4561431PubMed
20241,594A review of possible mechanisms of action of the antirheumatic drug, alclofenac.Curr Med Res Opin1975https://conductscience.org/library/papers/241594PubMed

See all 53 references

Cited by8

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 20 citations.

PMIDTitleJournalYearIn PapersSource
7,021,122Piroxicam: a review of its pharmacological properties and therapeutic efficacy.Drugs1981https://conductscience.org/library/papers/7021122PubMed
7,009,135Fenbufen: a review of its pharmacological properties and therapeutic use in rheumatic diseases and acute pain.Drugs1981https://conductscience.org/library/papers/7009135PubMed
6,386,426Piroxicam. A reappraisal of its pharmacology and therapeutic efficacy.Drugs1984https://conductscience.org/library/papers/6386426PubMed
6,352,138Clinical pharmacokinetics of non-steroidal anti-inflammatory drugs.Clin Pharmacokinet1983https://conductscience.org/library/papers/6352138PubMed
3,537,613Acute poisoning due to non-steroidal anti-inflammatory drugs. Clinical features and management.Med Toxicol1986https://conductscience.org/library/papers/3537613PubMed
391,529Flurbiprofen: a review of its pharmacological properties and therapeutic use in rheumatic diseases.Drugs1979https://conductscience.org/library/papers/391529PubMed
387,372Naproxen up to date: a review of its pharmacological properties and therapeutic efficacy and use in rheumatic diseases and pain states.Drugs1979https://conductscience.org/library/papers/387372PubMed
39,764Methods for evaluation of urinary excretion parameters of alclofenac after I.M. administration of its water soluble lysine salt in man.Eur J Drug Metab Pharmacokinet1979https://conductscience.org/library/papers/39764PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/21068

GET https://conductscience.org/api/papers/v1/21068/references?page=2